Association Between Metabolic Syndrome and Multiple Lesions of Intracranial Atherothrombotic Stroke: a Hospital-based Study

Overview

Journal Cardiovasc Diabetol

Publisher Biomed Central

Specialties Cardiology & Vascular Diseases
Endocrinology

Date 2015 Aug 14

PMID 26269150

Citations 6

Authors

Kazuhiko Kotani

Noriko Satoh-Asahara

Takuya Nakakuki

Hajime Yamakage

Akira Shimatsu

Tetsuya Tsukahara

Affiliations

Soon will be listed here.

Abstract

Background: With the increasing trend of metabolic syndrome (MetS) and atherothrombotic stroke (which can manifest as stroke lesion multiplicity), studies on the association between MetS and the clinical aspects of atherothrombotic stroke are of great interest. The present study aimed to investigate the association between MetS and multiple atherothrombotic strokes in patients with intracranial atherothrombotic stroke.

Methods: A retrospective study based on medical charts was conducted among patients (n = 202: 137 men/65 women) who were symptomatically admitted to the hospital with the first-ever atherothrombotic stroke. For the occurrence of multiple lesions of stroke, odds ratio [OR: 95% confidence interval (CI)] of MetS or its respective components was calculated using logistic regression models.

Results: Fifty-one percent of the men and 38% of women with stroke presented multiple regions. MetS was a significant factor that was associated with an increased risk of multiple regions in women [OR 4.3 (95% CI 1.4-13.5)], but not in men. According to the components of MetS, dyslipidemia was a significant factor that was positively associated with multiple regions in both men [OR 2.0 (95% CI 1.1-3.7)] and women [OR 3.2 (95% CI 1.1-9.1)].

Conclusion: MetS may be pathophysiologically associated with intracranial atherothrombotic stroke multiplicity in women in particular. Future studies are warranted to confirm the findings.

Citing Articles

Association of Mediterranean Diet with Cardiovascular Risk Factors and with Metabolic Syndrome in Subjects with Long COVID: BioICOPER Study.

Suarez-Moreno N, Gomez-Sanchez L, Navarro-Caceres A, Arroyo-Romero S, Dominguez-Martin A, Lugones-Sanchez C Nutrients. 2025; 17(4).

PMID: 40004984 PMC: 11858499. DOI: 10.3390/nu17040656.

The Relationship between the Mediterranean Diet and Vascular Stiffness, Metabolic Syndrome, and Its Components in People over 65 Years of Age.

Gomez-Sanchez L, Gomez-Sanchez M, Garcia-Ortiz L, Agudo-Conde C, Lugones-Sanchez C, Gonzalez-Sanchez S Nutrients. 2024; 16(20).

PMID: 39458459 PMC: 11510127. DOI: 10.3390/nu16203464.

Relationship between the Mediterranean Diet and Metabolic Syndrome and Each of the Components That Form It in Caucasian Subjects: A Cross-Sectional Trial.

Gomez-Sanchez L, Gomez-Sanchez M, Tamayo-Morales O, Lugones-Sanchez C, Gonzalez-Sanchez S, Marti-Lluch R Nutrients. 2024; 16(12).

PMID: 38931300 PMC: 11207079. DOI: 10.3390/nu16121948.

Phytosome Loading the Combined Extract of Mulberry Fruit and Ginger Protects against Cerebral Ischemia in Metabolic Syndrome Rats.

Palachai N, Wattanathorn J, Muchimapura S, Thukham-Mee W Oxid Med Cell Longev. 2020; 2020:5305437.

PMID: 32774678 PMC: 7397413. DOI: 10.1155/2020/5305437.

Molecular and functional characteristics of megakaryocytes and platelets in aging.

Esparza O, Higa K, Davizon-Castillo P Curr Opin Hematol. 2020; 27(5):302-310.

PMID: 32740036 PMC: 11776438. DOI: 10.1097/MOH.0000000000000601.

References

Uchiyama S . Impact of metabolic syndrome as a risk factor for atherothrombotic stroke. Intern Med. 2005; 44(10):1021-2. DOI: 10.2169/internalmedicine.44.1021. View

Ovbiagele B, Saver J, Lynn M, Chimowitz M . Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology. 2006; 66(9):1344-9. DOI: 10.1212/01.wnl.0000210530.46058.5c. View

Bang O . Intracranial atherosclerotic stroke: specific focus on the metabolic syndrome and inflammation. Curr Atheroscler Rep. 2006; 8(4):330-6. DOI: 10.1007/s11883-006-0012-1. View

Galassi A, Reynolds K, He J . Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006; 119(10):812-9. DOI: 10.1016/j.amjmed.2006.02.031. View

Milionis H, Kostapanos M, Liberopoulos E, Goudevenos J, Athyros V, Mikhailidis D . Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects. Int J Clin Pract. 2007; 61(4):545-51. DOI: 10.1111/j.1742-1241.2006.01269.x. View

Takahashi K, Bokura H, Kobayashi S, Iijima K, Nagai A, Yamaguchi S . Metabolic syndrome increases the risk of ischemic stroke in women. Intern Med. 2007; 46(10):643-8. DOI: 10.2169/internalmedicine.46.6094. View

Arenillas J, Moro M, Davalos A . The metabolic syndrome and stroke: potential treatment approaches. Stroke. 2007; 38(7):2196-203. DOI: 10.1161/STROKEAHA.106.480004. View

Mak K, Ma S, Heng D, Tan C, Tai E, Topol E . Impact of sex, metabolic syndrome, and diabetes mellitus on cardiovascular events. Am J Cardiol. 2007; 100(2):227-33. DOI: 10.1016/j.amjcard.2007.02.090. View

Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K . Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb. 2007; 14(4):155-8. DOI: 10.5551/jat.e537. View

10.

Park J, Kwon H . Association between metabolic syndrome and previous ischemic lesions in patients with intracranial atherosclerotic stroke. Clin Neurol Neurosurg. 2007; 110(3):215-21. DOI: 10.1016/j.clineuro.2007.10.016. View

11.

. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97. DOI: 10.1001/jama.285.19.2486. View

12.

Tanne D, Koren-Morag N, Graff E, Goldbourt U . Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor. Circulation. 2001; 104(24):2892-7. DOI: 10.1161/hc4901.100384. View

13.

Roman G . Vascular dementia revisited: diagnosis, pathogenesis, treatment, and prevention. Med Clin North Am. 2002; 86(3):477-99. DOI: 10.1016/s0025-7125(02)00008-1. View

14.

. New criteria for 'obesity disease' in Japan. Circ J. 2002; 66(11):987-92. DOI: 10.1253/circj.66.987. View

15.

Duvall W, Vorchheimer D . Multi-bed vascular disease and atherothrombosis: scope of the problem. J Thromb Thrombolysis. 2004; 17(1):51-61. DOI: 10.1023/B:THRO.0000036029.56317.d1. View

16.

Adams Jr H, Bendixen B, Kappelle L, Biller J, Love B, Gordon D . Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24(1):35-41. DOI: 10.1161/01.str.24.1.35. View

17.

Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S . Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care. 2005; 28(6):1463-71. DOI: 10.2337/diacare.28.6.1463. View

18.

Kurth T, Logroscino G . The metabolic syndrome: more than the sum of its components?. Stroke. 2008; 39(4):1068-9. DOI: 10.1161/STROKEAHA.107.505073. View

19.

Bokura H, Yamaguchi S, Iijima K, Nagai A, Oguro H . Metabolic syndrome is associated with silent ischemic brain lesions. Stroke. 2008; 39(5):1607-9. DOI: 10.1161/STROKEAHA.107.508630. View

20.

Li W, Ma D, Liu M, Liu H, Feng S, Hao Z . Association between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies. Cerebrovasc Dis. 2008; 25(6):539-47. DOI: 10.1159/000131672. View